LVW Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,344
Closed -$694K 239
2022
Q4
$694K Buy
9,344
+2,650
+40% +$180K 0.14% 115
2022
Q3
$399K Buy
6,694
+1
+0% +$60 0.09% 149
2022
Q2
$376K Buy
+6,693
New +$440K 0.08% 165

Other funds holding GMED

LVW Advisors's GMED Position: Q1 2023 in Review

LVW Advisors sold out of Globus Medical (GMED) in Q1 2023, closing a stake of 9,344 shares — an estimated $694K sold.

LVW Advisors first reported a position in GMED in Q2 2022 and held it in 3 quarters. The position peaked at $694K in Q4 2022. 390 funds tracked by Wall St. Rank hold GMED as of Q1 2023.

  • LVW Advisors reported no remaining Globus Medical position as of Q1 2023 after selling out during the quarter.
  • LVW Advisors sold 9,344 Globus Medical shares in Q1 2023, an estimated $694K.
  • LVW Advisors first reported a position in Globus Medical in Q2 2022 and held it in 3 quarters.
  • LVW Advisors's Globus Medical position peaked at $694K in Q4 2022.
  • 390 funds tracked by Wall St. Rank held Globus Medical as of Q1 2023.

Based on LVW Advisors's 13F filing for Q1 2023, filed 3 May 2023.